Joseph Loscalzo
Joseph Loscalzo
Professor of Medicine, Harvard Medical School
Verified email at
Cited by
Cited by
Harrison's principles of internal medicine, 19e
D Kasper, A Fauci, S Hauser, D Longo, J Jameson, J Loscalzo
Mcgraw-hill 1 (2), 2015
Network medicine: a network-based approach to human disease
AL Barabási, N Gulbahce, J Loscalzo
Nature reviews genetics 12 (1), 56-68, 2011
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
SOLVD Investigators*
New England Journal of Medicine 327 (10), 685-691, 1992
Endothelial cells in physiology and in the pathophysiology of vascular disorders
DB Cines, ES Pollak, CA Buck, J Loscalzo, GA Zimmerman, RP McEver, ...
Blood, The Journal of the American Society of Hematology 91 (10), 3527-3561, 1998
Biochemistry of nitric oxide and its redox-activated forms
JS Stamler, DJ Singel, J Loscalzo
Science 258 (5090), 1898-1902, 1992
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
SA Lipton, YB Choi, ZH Pan, SZ Lei, HSV Chen, NJ Sucher, J Loscalzo, ...
Nature 364 (6438), 626-632, 1993
Homocysteine and atherothrombosis
GN Welch, J Loscalzo
New England journal of medicine 338 (15), 1042-1050, 1998
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
Epic Investigators
New England Journal of Medicine 330 (14), 956-961, 1994
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
GUSTO Angiographic Investigators
New England Journal of Medicine 329 (22), 1615-1622, 1993
S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.
JS Stamler, DI Simon, JA Osborne, ME Mullins, O Jaraki, T Michel, ...
Proceedings of the National Academy of Sciences 89 (1), 444-448, 1992
Pulmonary arterial hypertension
HW Farber, J Loscalzo
New England Journal of Medicine 351 (16), 1655-1665, 2004
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
Writing Committee Members:, RC Pasternak, SC Smith Jr, ...
Circulation 106 (8), 1024-1028, 2002
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
JS Stamler, O Jaraki, J Osborne, DI Simon, J Keaney, J Vita, D Singel, ...
Proceedings of the National Academy of Sciences 89 (16), 7674-7677, 1992
Harrison's Principles of Internal Medicine: V. 1
S Hauser, DL Longo, JL Jameson, DL Kasper, J Loscalzo
McGraw-Hill Companies, Incorporated, 2012
Uncovering disease-disease relationships through the incomplete interactome
J Menche, A Sharma, M Kitsak, SD Ghiassian, M Vidal, J Loscalzo, ...
Science 347 (6224), 1257601, 2015
Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities
E Lubos, J Loscalzo, DE Handy
Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA, 2011
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.
MA Creager, JP Cooke, ME Mendelsohn, SJ Gallagher, SM Coleman, ...
The Journal of clinical investigation 86 (1), 228-234, 1990
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
JS Stamler, JA Osborne, O Jaraki, LE Rabbani, M Mullins, D Singel, ...
The Journal of clinical investigation 91 (1), 308-318, 1993
EH Awtry, J Loscalzo
Circulation 101 (10), 1206-1218, 2000
Vascular calcification: pathobiological mechanisms and clinical implications
RC Johnson, JA Leopold, J Loscalzo
Circulation research 99 (10), 1044-1059, 2006
The system can't perform the operation now. Try again later.
Articles 1–20